Harvoni (ledipasvir and sofosbuvir) for hepatitis C

MeSH terms

• Antiviral Agents / adverse effects
• Antiviral Agents / pharmacokinetics
• Antiviral Agents / pharmacology
• Antiviral Agents / therapeutic use*
• Benzimidazoles / adverse effects
• Benzimidazoles / pharmacokinetics
• Benzimidazoles / pharmacology
• Benzimidazoles / therapeutic use*
• Contraindications
• Drug Interactions
• Fluorenes / adverse effects
• Fluorenes / pharmacokinetics
• Fluorenes / pharmacology
• Fluorenes / therapeutic use*
• Hepatitis C / drug therapy*
• Hepatitis C / nursing
• Humans
• Nurse Practitioners
• Patient Education as Topic
• Practice Guidelines as Topic
• Sofosbuvir
• Uridine Monophosphate / adverse effects
• Uridine Monophosphate / analogs & derivatives*
• Uridine Monophosphate / pharmacokinetics
• Uridine Monophosphate / pharmacology
• Uridine Monophosphate / therapeutic use